Chronic Myeloid Leukemia
Excerpt
The number of people living with CML (prevalence) has doubled since 2001, and this trend is expected to continue. The growing prevalence of CML reflects important advances in the treatment of people with CML in the last several years. Since 2001, three new drugs have been approved, and there are now several effective therapies for people with CML. This progress is expected to continue as a result of the concerted scientific research effort that is under way and because of patients' participation in clinical trials.
